Yatai pharm(002370.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Yatai pharm
002370.SZ
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. It also provides various antibiotic and non-antibiotic drugs.
2.805 T
002370.SZMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking135/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE9.60%B
    • Profit Margin31.91%A
    • Gross Margin35.55%C
  • Growth ScoreD
    • Revenue YoY-10.88%E
    • Net Profit YoY244.91%A
    • Total Assets YoY-14.45%E
    • Net Assets YoY12.01%B
  • Cash ScoreD
    • Cash Flow Margin14.90%D
    • OCF YoY-10.88%E
  • Operating ScoreD
    • Turnover0.24D
  • Debt ScoreA
    • Gearing Ratio9.34%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Yatai Pharm: The cumulative deviation of the stock price increase over the past two days exceeds 20%, warning of risks

    Zhitong·
    SZ
    002370
    +1.57%
    Zhitong·
    SZ
    002370
    +1.57%

    A-share innovative drug concept stocks are active again, Sunshine Guojian Pharmaceutical rose over 10% to a new high, Yatai Pharm had two consecutive limit-ups, WECOME rose over 10%, and Baicheng Pharmaceutical, ALK, and Fushine followed suit

    Zhitong·
    SZ
    300878
    -1.60%
    SZ
    300497
    -0.48%
    SZ
    002940
    +3.79%
    Zhitong·
    SZ
    300878
    -1.60%
    SZ
    300497
    -0.48%
    SZ
    002940
    +3.79%

    Yatai Pharm released its performance for the first three quarters, with a net profit attributable to the parent company of 97.195 million yuan, a year-on-year increase of 2909.49%

    Zhitong·
    SZ
    002370
    +1.57%
    Zhitong·
    SZ
    002370
    +1.57%

    The actual controller of Yatai Pharm will change to Qiu Zhongxun, and trading will resume on October 14

    Zhitong·
    SZ
    002370
    +1.57%
    Zhitong·
    SZ
    002370
    +1.57%

    Yatai Pharm: Signed a share transfer agreement, control rights are expected to change

    Zhitong·
    SZ
    002370
    +1.57%
    Zhitong·
    SZ
    002370
    +1.57%
    © 2026 Longbridge｜Disclaimer